tirzepatide stinging at injection site reactions Tirzepatide Injection Site Reaction: 6

Notably, Trulicity carries a higher risk of low blood sugar (hypoglycemia) when used with insulin or sulfonylureas (up to 20%), while Zepbound shows lower hypoglycemia rates (~5%)

Further RCTs of high quality are still needed to clarify this issue

Semaglutide GLP-1 typically does not suppress appetite immediately

- If a note contains multiple distinct functional-assessment timepoints, return multiple JSON objects

Those looking to enhance recovery time, improve skin quality, increase energy levels, and potentially mitigate signs of aging might also be interested

In Eli Lillys SURMOUNT-1 trial, participants taking tirzepatide lost up to 22.5% of their body weight over 72 weeks